. Taken together, MID is the only IgD-binding protein in Moraxella.
Furthermore, the novel T cell independent antigen MID 962-1200 may together with MID 962-1200 -GFP be considered as promising reagents in the study of IgD-dependent B cell activation.
INTRODUCTION
Moraxella catarrhalis is an uncapsulated Gram-negative diplococcus that can be detected in nasopharyngeal cultures in 66 % of children during the first year of life and in approximately 4 % of adults at any given time. Despite M. catarrhalis often is considered as a commensal, the bacterium plays an important role in respiratory tract infections in both children and adults [1] [2] [3] [4] . More than 80 % of children under the age of three years will be diagnosed with acute otitis media. After Haemophilus influenzae and pneumococci, M. catarrhalis is the third most common bacterial species causing acute otitis media. In adults and the elderly, M. catarrhalis is a common cause of lower respiratory tract infections particularly in those with predisposing conditions, e.g., chronic obstructive pulmonary disease (COPD).
Moreover, M. catarrhalis is often implicated as a cause of sinusitis in both children
and adults.
Despite M. catarrhalis is acknowledged as a human pathogen, only a few reports exist on its specific virulence factors. Interestingly, M. catarrhalis hampers the host innate immune system by conferring serum resistance [5, 6] . We have recently shown that
M. catarrhalis interferes with complement activation pathway by binding C4b
binding protein (C4BP) and C3 to UspA1 and UspA2 [7, 8] .
In addition to the interaction with C4BP, M. catarrhalis displays a strong affinity for soluble IgD [9] . IgD-binding at the cellular level explains the strong mitogenic effects on human lymphocytes by M. catarrhalis [10] [11] [12] [13] . We have previously isolated and characterized the high molecular weight surface protein "Moraxella IgD-binding protein" (MID) that displays a high affinity for both soluble and surfacebound IgD [14] . The presence of MID, also designated Hag, has been confirmed by two other laboratories [15, 16] . For formaldehyde-killing, bacteria were grown overnight in Nutrient Broth (Oxoid, Basingstoke Hampshire, England), harvested and washed in phosphate-balanced saline (PBS), pH 7.2 by centrifugation. Thereafter, they were immediately resuspended in 0.5 % formaldehyde for 3 h at room temperature followed by heat treatment at 80 °C for 3 min. After being washed in PBS, the bacteria were suspended in RPMI 1640 medium (Gibco, Paisley, UK) and stored in aliquotes at -20 °C.
DNA cloning and protein expression
The truncated MID constructs MID 962-1200 and MID 1000-1200 were amplified by PCR using specific primers introducing the restriction enzyme sites BamHI and HindIII catarrhalis (pET26-MID) was used as template [14] . The resulting PCR products were cloned into pET26b(+) (Novagen, Darmstadt, Germany). To avoid presumptive toxicity, the resulting plasmids were first transformed into the host E. coli DH5α.
Thereafter, the plasmids encoding for the MID fragments were transformed into the expressing host BL21(DE3) (Novagen). To produce recombinant proteins, bacteria were grown to mid-log phase (OD 600 0.5-1.0) followed by 3.5 hrs of induction with 1 mM isopropyl-1-thio-β-D-galactoside (IPTG) resulting in overexpression of the proteins.
For construction of the fusion protein MID 962-1200 -GFP, the MID 962-1200 cassette was amplified using the specific primers Gel-electrophoresis SDS-PAGE (12 %) was run as described [14] . Briefly, samples of purified MID Enzyme linked immunosorbent assay (ELISA)
The interactions between IgD and the MID derived proteins were analysed in ELISA. In some experiments, a T cell cytokine rich supernatant was used. To produce T cell cytokines, T lymphocytes that were obtained from the "flow-through" during positive B cell selection (as described above) were incubated with 1 µg/ml PHA and 50 ng/ml PMA for 24 hrs. After centrifugation, the supernatant was thoroughly dialysed catarrhalis strains using an anti-MID 902-1200 polyclonal antibody proved the absence of MID at the cell surface. In Figure 1A , the flow cytometry analysis of M. catarrhalis BBH18 strain is exemplified. The wild type BBH18 strongly bound soluble IgD, whereas the corresponding MID deficient mutant was negative for IgD-binding (Fig.   1B) .
To demonstrate the specificity of the MID-dependent binding to human B cells, the M. catarrhalis wild type and the MID-deficient M. catarrhalis mutant were FITCconjugated followed by incubation with PBLs. B lymphocytes were visualized by RPE-conjugated anti-CD19 mAbs. The high MID-expressing wild type M. catarrhalis BBH18 bound to CD19 + B cells (Fig. 1C) , whereas the MID-deficient mutant did not (Fig. 1D) . Furthermore, neither the MID expressing Moraxella strain nor the mutant bound to the T cells (the CD19 -cell population). A FITC-conjugated anti-human IgD pAb was used as positive control (Fig. 1E) . Similar results were obtained with the M.
catarrhalis RH4 strain and the corresponding RH4Δmid mutant (data not shown).
We also incubated human PBLs with the M. catarrhalis BBH18 and RH4 wild type bacteria and their MID deficient counterparts. Cells were pulsed with [ 3 H]-thymidine and the uptake was analysed by scintillation counting. Interestingly, PBLs incubated with BBH18Δmid and RH4Δmid showed a 75 % reduced proliferation as compared to cells stimulated with the wild type MID-expressing bacteria (Fig. 2) . Thus, the IgD- 3A) . MID 962-1200 was recombinantly produced in E. coli and purified by affinity chromatography. In addition, a non-IgD-binding fragment (MID 1000-1200 ) was manufactured to be included as a negative control (Fig. 3A and B) . revealed by an IgD ELISA, whereas MID 1000-1200 did not bind IgD (Fig. 3C) . Thus, the ability of MID 962-1200 -GFP to bind soluble IgD was not affected by the GFP fusion partner.
To analyse whether the MID 962-1200 -GFP fusion protein bound to the B cell receptor (BCR) IgD, human PBLs were isolated. PBLs were incubated with MID 962-1200 -GFP and anti-human CD19 RPE followed by flow cytometry analyses and fluorescence microscopy. As can be seen in Figure 4B , MID 962-1200 -GFP efficiently bound to the CD19 + B cells. The interaction was completely blocked when the PBLs were preincubated with anti-human IgD-Fab (Fig. 4C) . Furthermore, the specificity for the Fig. 4H and I) . In contrast, any green fluorescence could not be detected when PBLs were incubated with GFP alone (Fig. 4L) . Taken The resulting CHO-IgD transfectants were confirmed by flow cytometry using a mAb directed against human IgD (Fig. 5A) Figure 6A , MID 962-1200 at 0.5 µg/ml was optimal to induce a vigorous proliferation. Interestingly, similar results were obtained with the MID 962-1200 -GFP fusion protein (Fig. 6B) . However, since the GFP protein is almost twice as large as MID , more molecules were required to achieve the same level of proliferative response. Analysis of the kinetics revealed that the strongest proliferation was observed at 96 hrs (Fig. 6C) . A similar kinetics was seen with MID 962-1200 -GFP (not shown). In contrast, the recombinant non-IgD-binding MID 1000-1200 fragment, which was included as a negative control, did not induce any proliferation. Thus, MID 962-1200 and the GFP -fusion protein both induced lymphocyte proliferation.
To determine the importance of the CD40/ CD40L interaction between T cells and MID 962-1200
-induced B cells, PBLs were preincubated with a mixture of neutralizing anti-CD40L mAb. As can be seen in Figure 6D , blocking of the CD40L completely inhibited the proliferation. This result proved that the physical B and T cell interaction was crucial for MID followed by incubation with PBLs. Interestingly, the proliferation of the PBLs dramatically decreased when MID 962-1200 had been incubated at 60 and 100°C (Fig. 7) was seen in the presence of 0.5 or 1.0 µg/ml MID 962-1200 without cytokines (Fig. 8A) .
In contrast, when the T cell cytokine-rich supernatant was supplemented together with coli lipopolysaccharide (LPS) induced the B lymphocytes (Fig. 8A) .
Experiments with the T cell supernatant revealed that cytokines were crucial for optimal B cell activation in the presence of MID . To further examine the specific need for T cell cytokine co-stimulatory activation, the cytokines IL-2, IL-4, and IL-10 were separately incubated with MID . Interestingly, when IL-4 or IL-2 was supplemented together with MID 962-1200
, an increased proliferation was observed as compared to cells incubated with the truncated MID 962-1200 fragment only (Fig. 8B) .
MID 962-1200 at 0.5 µg/ml together with IL-4 increased the proliferation up to 9-fold, whereas MID 962-1200 together with IL-2 resulted in a 4.5-fold increase. Addition of IL-together with MID 962-1200 no significant proliferation could be detected (Fig. 8B) . 
DISCUSSION
The respiratory pathogen M. catarrhalis is a strong IgD-binding bacterium [14, 17] .
In the present paper we show, by using MID-deficient Moraxella mutants, that MID was the only M. catarrhalis outer membrane protein interacting with IgD (Fig. 1) .
Furthermore, the truncated protein MID 962-1200 activated human B cells in the range 0.1 to 5 µg/ml when either T cells (Fig. 6) or T cell cytokines (Fig. 8) were supplied.
Importantly, the non-IgD binding fragment MID 1000-1200 , which in addition to MID 962-1200 was produced in E. coli, did not induce any B cell proliferation. MID 1000-1200 also failed to attract soluble IgD when analysed in ELISA (Fig. 3) . Haemophilus somnus have been reported [23] [24] [25] . An Ig-Fc-receptor has also been purified from H. somnus [26] . Furthermore, the respiratory pathogen H. influenzae strongly attracts human IgD, albeit the particular Ig-binding protein has not yet been found [27] .
In contrast to Gram-negative species, several examples exist of Gram-positive bacteria that attract immunoglobulins in a nonimmune manner. Staphylococcus aureus protein A (SpA) is the most characterized protein and binds to the Fc part of IgG [28, 29] . SpA also binds a fraction of Ig-molecules of all classes due to the so-called 'alternative' binding to VH3 [30] . In addition to SpA, an S. aureus gene encoding another Ig-binding protein has been found [31] . Protein G isolated from group C and G streptococci of human origin has a distinct affinity for the same site on the human Fc-fragment of IgG as SpA, but also interacts with IgG Fab fragments [32, 33] . Protein H, isolated from Streptococcus pyogenes, is able to compete for the same region of IgG-Fc with SpA and protein G [34] . In addition, S. pyogenes produces an antigenically and functionally heterogenous group of M-like proteins with different Ig-binding specificities [35] . Protein Bac or the B-antigen is an IgA-binding protein expressed by certain strains of group B streptococci [36] . Finally, protein L, a surface component of Peptostreptococcus magnus, has affinity for all classes of Ig through an interaction with determinants present in the variable region of κ-light-chains [37] .
The outer-membrane glycolipids of M. catarrhalis lack the repeating O-antigen polysaccharides of lipopolysaccharides (LPS) and are hence designated lipooligosaccharides (LOS) [38] . These occur commonly in non-enteric Gram-negative bacteria, such as those that colonise the mucosal surfaces of the upper respiratory tract [39] . The LOS of M. catarrhalis consists of lipid A plus a core polysaccharide and one oligosaccharide [40] . The lipid A component is similar to that of other Gramnegative bacteria [41] and cross-reacts with lipid A of the Enterobacteriaceae, but it lacks the 3-hydroxytetradecanoic acid that normally is present in enteric bacteria [40] .
We show that lymphocyte activation in the presence of MID-deficient M. catarrhalis mutants was significantly decreased compared to when cells were incubated with wild type bacteria expressing high levels of MID (Fig. 2) . These experiments did not only demonstrate the importance of MID as the major B cell stimulus of moraxella´s but also that M. catarrhalis LOS plays a minor role in human B lymphocyte activation. that Th2-derived cytokines are required for MID-dependent class-switch [13] .
MID and other antigens that can induce antibody responses without obvious ("physical") T cell help are classified as T cell independent (TI) antigens [13, 42] .
This phenomenon was initially evaluated by the ability of antigens to elicit antibody responses in T cell-deficient nude mice. In general, TI antigens have repeating determinants that can be recognized by antibody receptors on B lymphocytes. TI antigens have been subdivided into two types based upon their differential ability to induce Ab responses in neonates and in CBA/N mice, the later having an X-linked immune deficiency [43] . Dextran-conjugated anti-IgD antibodies can at very low concentrations induce a B cell signal and have as a representative TI-2 antigen been used in several experimental models [42, 44] . In contrast to other TI-2 antigens, the dextran-conjugated anti-IgD antibodies do not result in antigen specific antibodies but induce a polyclonal activation [45] . Activation by MID most likely also results in a polyclonal antibody production and by analogy with dextran-conjugated anti-IgD antibodies MID, as an activator through the IgD BCR, may also be regarded as a TI-2
antigen.
In spite of the fact that MID 962-1200 activated the B cells without the presence of physical T cell help, addition of cytokines was required to achieve similar B cell proliferation as compared to cell cultures with PBLs. The increased proliferation in cultures with PBLs can be explained by co-stimulatory activation via the CD40-CD40L and cytokines. Indeed, blocking of the CD40L prior to stimulation with MID 962-1200 resulted in a decreased proliferation (Fig. 6D) . It has also been shown that recombinant CD40L strongly enhances MID-dependent B cell proliferation [13] .
Since MID 962-1200 was covalently attached to Sepharose beads or in some experiments bound to the microtiter plate plastic surface, MID 962-1200 was most likely not internalized, processed, or presented to T cells on MHC class II. The T cells might, however, be activated through the release of B cell cytokines, e.g., IL-6 (Fig. 9) .
Finally, it cannot be excluded that monocytes in the PBL preparations also were activated by lymphocyte cytokines.
An interesting fact is that a high number of IgD-producing plasma cells have been observed in the lymphoid tissue from nasopharyngeal tonsils and lacrimal, parotid, and lactating mammary glands as compared with spleen lymph nodes and glandular tissue of the gastrointestinal tract [46, 47] . A substantial local IgD synthesis is found both in nasopharynx and in the middle ear cavity [48, 49] . In approximately 20 % of middle ear effusions examined, a content of more than 600 mg/l of IgD can be 
